Maytansine

DB19582InvestigationalSmall molecule

Maytansine is a small molecule drug. Maytansine is under investigation in clinical trial NCT04189211 (A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients). Maytansine has a monoisotopic...

Mechanism: Pharmacologically active on Tubulin
Curator reviewed
Formula / weight: C₃₄H₄₆ClN₃O₁₀ · 692.2 g/mol (avg)
Also known as: Maitansine
Code names: NSC-153858

Resolves to

Compound

UNII14083FR882CAS35846-53-8

Structure

InChIKeyWKPWGQKGSOKKOO-LOWKUAJRSA-NSMILES

[H][C@@]12O[C@@]1(C)[C@H](CC(=O)N(C)C1=CC(C\C(C)=C\C=C\[C@@H](OC)[C@@]3(O)C[C@]([H])(OC(=O)N3)[C@H]2C)=CC(OC)=C1Cl)OC(=O)[C@H](C)N(C)C(C)=O

What you can answer from here — as of August 31, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which companies are running trials of Maytansine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account